Administrative Core
Administrative Core
批准号:
10684067
负责人:
Pamela J Lein
金额:
$43.21万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
AcuteAdministratorAdvanced DevelopmentAnalytical ChemistryAuthorization documentationAwardCalendarChemicalsCholinesterase InhibitorsChronicCollaborationsCommunicationCommunitiesDataDatabase Management SystemsEducational workshopEnsureEnvironmental HealthEquipment and supply inventoriesEventFederal GovernmentFosteringFundingGeneral PopulationGoalsGovernment AgenciesGrantHazardous SubstancesHuman ResourcesIACUCIndividualIntellectual PropertyIntoxicationInvestigational DrugsLeadershipLegal patentLogisticsManuscriptsMedical ResearchMissionMonitorNeurologicOnline SystemsOrganophosphatesOutcomePharmaceutical ChemistryPilot ProjectsPoliciesProceduresPubMedPublicationsQualifyingReadinessReagentRegulationReportingResearchResearch InstituteResearch PersonnelResearch Project GrantsResource SharingSafetyScienceScientistSecureSecurityStrategic PlanningSystemTechnology TransferTherapeuticTherapeutic AgentsTrainingUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesWorkauthoritycentral databasechemical threatcholinergicdata sharingeducation researchinnovationinterestmedical countermeasuremeetingsmemberoperationpre-Investigational New Drug meetingprogramsrecruitresearch and developmentsuccesssynergismtherapeutic candidatetherapeutic developmenttimelineweb site
中文摘要
项目摘要-管理核心
新的加州大学戴维斯分校卓越对抗中心的总体目标是确定和推进
开发治疗策略以减轻个体的长期不良神经后果
谁在有机磷(OP)胆碱酯酶急性中毒引发的胆碱能危象中幸存下来
抑制剂。该中心由三个科学项目、三个科学核心、一个研究教育组成
CORE,一个新兴的科学和科学家试点项目计划,以及多个委员会--所有这些都将
紧密合作,确保成功。行政核心将集中协调、沟通
以及项目和核心之间的整合,并促进整个中心的协同作用,最终确保
中心达到了与美国国立卫生研究院对抗计划官员(S)合作建立的年度里程碑。活动
将包括提供全面的科学领导、财政监督和后勤支持以及援助
传播研究成果,鼓励和促进与外部调查人员共享数据。
此外,管理核心将协调中心与加州大学戴维斯分校的管理和
外部实体,如国家卫生研究院抵消行政,中心的外部咨询委员会,较大的
对抗研究社区,美国食品和药物管理局(FDA),生物医学先进
研究和发展局(BARDA)和潜在的商业合作伙伴。核心的目标是
为:(1)提供科学的领导和后勤支持,协调和整合中心的活动和
促进中心调查人员之间的互动,以达到中心的年度里程碑;(2)管理新出现的
科学和科学家试点项目计划(ESSP3);(3)促进中心之间的数据和资源共享
调查员和其他反调查员;(4)提供预算监督和赠款管理;(5)
确保人员、材料、数据和设施的安全;(6)追求知识产权(IP)
战略,并确定、接触和协调与商业伙伴的沟通;以及(7)协调
与FDA、BARDA和其他联邦政府机构合作。
英文摘要
Project Summary – Administrative Core
The overall objective of the new UC Davis CounterACT Center of Excellence is to identify and advance the
development of therapeutic strategies for mitigating long-term, adverse neurologic consequences in individuals
who survive the cholinergic crisis triggered by acute intoxication with organophosphate (OP) cholinesterase
inhibitors. The Center is comprised of three scientific Projects, three scientific Cores, a Research Education
Core, an Emerging Science and Scientists Pilot Project Program, and multiple committees — all of which will
work closely together to ensure success. The Administrative Core will centralize coordination, communication
and integration among the Projects and Cores and foster synergy across the Center, ultimately ensuring the
Center meets annual milestones established in collaboration with NIH CounterACT program officer(s). Activities
will include providing overall scientific leadership, fiscal oversight, and logistical support as well as assistance
with disseminating research findings and encouraging and facilitating data sharing with external investigators.
Additionally, the Administrative Core will coordinate Center interactions with the UC Davis administration and
external entities, such as the NIH CounterACT administration, the Center’s External Advisory Board, the larger
CounterACT research community, the U.S. Food and Drug Administration (FDA), the Biomedical Advanced
Research and Development Authority (BARDA), and potential commercial partners. The Core’s objectives are
to: (1) Provide scientific leadership and logistics support to coordinate and integrate Center activities and
promote interactions among Center investigators to meet annual Center milestones; (2) Administer the Emerging
Science and Scientists Pilot Project Program (ESSP3); (3) Facilitate data and resource sharing among Center
investigators and other CounterACT investigators; (4) Provide budgetary oversight and grant management; (5)
Ensure the safety and security of personnel, materials, data and facilities; (6) Pursue intellectual property (IP)
strategies, and identify, engage and coordinate communications with commercial partners; and (7) Coordinate
with FDA, BARDA and other federal government agencies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Reduction of Pro-Inflammatory Signaling
-
批准号:10684082
-
项目类别:
-
资助金额:$49.11万
-
财政年份:2022
-
负责人:Pamela J Lein
-
依托单位:
Ketogenic diet approaches to slow disease progression in a rat model of Alzheimer's disease
-
批准号:9977496
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2020
-
负责人:Pamela J Lein
-
依托单位:
Identifying Molecular Targets for the Proconvulsant Activity of TETS
-
批准号:9905564
-
项目类别:
-
资助金额:$18.7万
-
财政年份:2019
-
负责人:Pamela J Lein
-
依托单位:
Does air pollution increase risk of AD in a genetically susceptible animal model?
-
批准号:9126737
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2016
-
负责人:Pamela J Lein
-
依托单位:
Administrative Core
-
批准号:10204118
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Administrative Core
-
批准号:8411734
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Mitigation of Neurological Damage Following Seizures
-
批准号:10204125
-
项目类别:
-
资助金额:$101.66万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:9142832
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
-
批准号:10204117
-
项目类别:
-
资助金额:$364.92万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:8925299
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
CounterACT 2020 Annual Meeting
-
批准号:9925004
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:8533058
-
项目类别:
-
资助金额:$332.98万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:8730727
-
项目类别:
-
资助金额:$327.28万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:9060480
-
项目类别:
-
资助金额:$15.47万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:8851844
-
项目类别:
-
资助金额:$7.71万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
-
批准号:8332981
-
项目类别:
-
资助金额:$319.22万
-
财政年份:2012
-
负责人:Pamela J Lein
-
依托单位:
Identification of novel therapeutic approaches for TETS and OP intoxication
-
批准号:8153115
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2010
-
负责人:Pamela J Lein
-
依托单位:
Identification of novel therapeutic approaches for TETS and OP intoxication
-
批准号:8019767
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2010
-
负责人:Pamela J Lein
-
依托单位:
Molecular and Cellular Basis of PCB Developmental Neurotoxicity
-
批准号:7743503
-
项目类别:
-
资助金额:$47.4万
-
财政年份:2008
-
负责人:Pamela J Lein
-
依托单位:
Molecular and Cellular Basis of PCB Developmental Neurotoxicity
-
批准号:8197470
-
项目类别:
-
资助金额:$45.89万
-
财政年份:2008
-
负责人:Pamela J Lein
-
依托单位:
海外基金